
Switzerland Very Close To Tariff Deal With The US, Says Roche CEO
-
Italiano
it
Ceo Roche:“Accordo fra Berna e Washington a giorni, se non a ore”
Original
Read more: Ceo Roche:“Accordo fra Berna e Washington a giorni, se non a ore
Schinecker bases his optimism on the close contact the pharmaceutical giant maintains with the Swiss authorities on this issue.
+Get the most important news from Switzerland in your inbox .
“I believe that an agreement is a matter of days, if not hours,” the pharma CEO said in statements reported by the AWP news agency. Switzerland is currently awaiting a response from the United States to a proposal that has been submitted. The pharmaceutical industry also plays a central role in the affair: US President Donald Trump has in fact repeatedly threatened to impose high tariffs on drug imports.
More More Roche boss says 'very easy' to cut US drug prices by 50%This content was published on Jul 24, 2025 Swiss pharma group Roche is in talks with Washington to bypass middlemen and sell directly to consumers.
Read more: Roche boss says 'very easy' to cut US drug prices by 50
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Bydfi Joins Korea Blockchain Week 2025 (KBW2025): Deepening Web3 Engagement
- Cregis Joins TOKEN2049 Singapore 2025
- SPAYZ.Io White Paper Explores Opportunities, Challenges And Ambitions In Payments Industry
- Cregis At TOKEN2049 Singapore 2025: Unlocking The Next Frontier Of Adoption
- Space And Time Integrates USDC Payments For ZK Coprocessing To Expand Access To Verifiable Onchain Compute
- Codego Launches Whitelabel Devices Bringing Tokens Into Daily Life
Comments
No comment